Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zhengqing Fengtongning SR Tablets for Rheumatoid Arthritis
ChiCTR-IPR-16008793Phase 4Recruiting
- Sponsor
- Southwest Hospital of Army Medical University
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of zhengqing fengtongning in rheumatoid arthritis (RA) (3 arms), sponsored by Southwest Hospital of Army Medical University. Primary endpoint: ACR20 response at week 24. Started Jul 2016; status: recruiting.
02
Drugs
zhengqing fengtongning
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on ChiCTR-IPR-16008793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16008793.